RUSSO, Emilio
 Distribuzione geografica
Continente #
NA - Nord America 5.870
AS - Asia 2.758
EU - Europa 2.525
SA - Sud America 657
AF - Africa 90
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 26
Totale 11.979
Nazione #
US - Stati Uniti d'America 5.517
SG - Singapore 1.283
IT - Italia 1.049
CN - Cina 620
BR - Brasile 512
DE - Germania 366
GB - Regno Unito 305
CA - Canada 295
SE - Svezia 239
VN - Vietnam 192
FI - Finlandia 176
IN - India 176
HK - Hong Kong 103
RU - Federazione Russa 55
AE - Emirati Arabi Uniti 50
AU - Australia 50
FR - Francia 48
TR - Turchia 48
NL - Olanda 46
AR - Argentina 41
ID - Indonesia 40
MX - Messico 39
RO - Romania 36
JP - Giappone 34
CO - Colombia 32
ZA - Sudafrica 32
PL - Polonia 29
ES - Italia 28
BD - Bangladesh 26
PK - Pakistan 25
EC - Ecuador 24
EG - Egitto 23
EU - Europa 22
UA - Ucraina 21
CL - Cile 19
EE - Estonia 18
IL - Israele 18
IR - Iran 16
SA - Arabia Saudita 16
GR - Grecia 15
IQ - Iraq 15
TW - Taiwan 15
CH - Svizzera 13
KR - Corea 13
CZ - Repubblica Ceca 12
MY - Malesia 11
PH - Filippine 11
AT - Austria 10
PY - Paraguay 9
PT - Portogallo 8
BE - Belgio 7
IE - Irlanda 7
MT - Malta 7
UZ - Uzbekistan 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
KE - Kenya 6
MD - Moldavia 5
NG - Nigeria 5
NP - Nepal 5
PE - Perù 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
BO - Bolivia 4
HR - Croazia 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AF - Afghanistan, Repubblica islamica di 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
OM - Oman 3
TN - Tunisia 3
UG - Uganda 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CU - Cuba 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
Totale 11.964
Città #
Chandler 981
Singapore 615
Dallas 518
Santa Clara 338
Hefei 310
Milan 308
Munich 277
Princeton 275
Lawrence 268
Ottawa 190
London 183
Ashburn 179
Wilmington 154
Catanzaro 153
Chicago 149
Des Moines 100
Hong Kong 95
Turku 93
Boardman 90
Helsinki 74
Ho Chi Minh City 73
Los Angeles 57
New York 56
São Paulo 54
Redwood City 53
Hanoi 41
Rome 41
Brooklyn 40
Shanghai 33
Guangzhou 32
Boston 29
The Dalles 28
Montreal 26
Warsaw 24
Columbus 23
Norwalk 23
Tokyo 23
Redmond 21
Atlanta 20
Council Bluffs 20
Melbourne 20
Pune 20
Naples 19
Toronto 19
Istanbul 18
Shenzhen 18
Florence 17
Amsterdam 16
Bogotá 16
Johannesburg 16
Padova 16
Rio de Janeiro 15
Timisoara 15
Beijing 14
Chennai 14
Hyderabad 14
San Nicola Manfredi 14
Curitiba 13
Falls Church 13
Phoenix 13
San Francisco 13
Stockholm 13
Jakarta 12
Seattle 12
Bengaluru 11
Mumbai 11
Olomouc 11
West Jordan 11
Ankara 10
Bari 10
Haiphong 10
Messina 10
Mexico City 10
Nanjing 10
Palermo 10
Philadelphia 10
Sydney 10
Augusta 9
Guayaquil 9
Hanover 9
Latina 9
Santa Maria 9
Vallefiorita 9
Ann Arbor 8
Assago 8
Cairo 8
Charlotte 8
Civitavecchia 8
Delhi 8
Denver 8
Houston 8
Madrid 8
Manchester 8
Nuremberg 8
Patna 8
Riyadh 8
Vienna 8
Brasília 7
Campinas 7
Curinga 7
Totale 6.758
Nome #
Adherence to therapy and adverse drug reactions: is there a link? 247
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 228
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 141
Genetics of reflex seizures and epilepsies in humans and animals 135
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 128
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 113
Role of anatomical variations in chronic non polipoid rhinosinusitis 108
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 88
Efficacy and safety of bevacizumab in glioblastomas 85
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 84
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 84
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 84
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 83
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 81
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 79
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis An Observational Study 70
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 69
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 68
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 66
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 65
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 65
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome 65
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 63
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 63
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 62
Classical differentiation protocols upregulate the expression of the axon guidance genes PLXNA2 and SEMA3C in SH-SY5Y neuroblastoma cells 61
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 61
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 60
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 60
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 60
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 60
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 60
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 59
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 59
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 58
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 58
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 57
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 57
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 57
Melaena following use of the cholinesterase inhibitor rivastigmine 56
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 55
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 55
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 55
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 55
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 54
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 54
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 54
Adverse drug reactions related to drug administration in hospitalized patients. 54
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 54
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 54
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 53
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 53
Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy 53
New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review 52
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 51
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 51
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 50
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 50
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 50
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 50
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 50
Pharmacokinetic considerations about antiseizure medications in the elderly 50
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 50
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 50
Status epilepticus in pregnancy: a literature review and a protocol proposal 49
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System 49
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 49
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 49
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 48
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 48
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 48
Abatacept in psoriatic arthritis: Case report and short review. 48
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 48
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 48
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 47
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 47
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 47
Renal denervation for resistant hypertension 47
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 47
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 46
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 46
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 46
Microbiota-gut brain axis involvement in neuropsychiatric disorders 46
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  46
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 46
A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients 46
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 46
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 46
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 45
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 45
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis 45
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 45
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 45
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 45
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy 45
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 45
Epidemiology and outcomes of status epilepticus 45
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study. 44
Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study 44
UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy 44
Totale 6.234
Categoria #
all - tutte 135.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021548 0 0 0 40 49 203 60 21 77 46 43 9
2021/2022943 19 14 20 229 39 32 30 180 113 91 148 28
2022/20232.580 581 211 90 234 241 224 18 183 395 165 176 62
2023/20241.410 204 175 139 108 102 256 82 53 24 78 53 136
2024/20253.881 532 196 186 151 269 488 230 155 451 185 430 608
2025/20262.526 470 835 1.027 194 0 0 0 0 0 0 0 0
Totale 12.344